In addition, potent cytotoxicity by cytotoxic CD8+ T lymphocytes has been demonstrated against the following tumors, including carcinoma, sarcoma, myeloma, and melanoma, as well as newly isolated lymphoma and leukemia cells, in an HLA-A*0201-specific manner (Figure 4). This evidence concerns the gene CD8A and leukemia.